Madrigal Pharmaceuticals Inc
MDGL
Market Cap$9.76B
Close$
$172.01
60.1% downside
Current Fair Value
60.1% downsideOvervalued by 60.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.76 Billion |
|---|---|
| Enterprise Value | $9.69 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-21.9 |
| Beta | -1.03 |
| Outstanding Shares | 22,207,017 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -34.49 |
|---|---|
| PEG | 48.35 |
| Price to Sales | 18.75 |
| Price to Book Ratio | 13.91 |
| Enterprise Value to Revenue | 18.8 |
| Enterprise Value to EBIT | -34.47 |
| Enterprise Value to Net Income | -35 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Madrigal Pharmaceuticals Inc
CEO: Rebecca Taub